Name | Type | Posted | Actions |
|---|---|---|---|
D_Amendment 01_RFP 75N95023R00019_031723.pdf | Mar 17, 2023 |
Toxicological Evaluations of Potential Medications to Treat Drug Abuse
Contact and place of performance
Polina Klimenkova
Not specified
The purpose of this amendment # 01 is to clarify the RFP requirements by responding to questions submitted. Please see the attached Amendmend 01 for more information.
This federal opportunity involves toxicological evaluations of potential medications to treat drug abuse under solicitation number 75N95023R00019. The requirement is classified under NAICS 541715 for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and PSC AN11 for HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH. This special notice supports the research and development of medical treatments aimed at addressing substance use disorders.
Amendment 01 was issued on March 17, 2023, to clarify the Request for Proposals requirements by providing responses to submitted questions. A single attachment titled D_Amendment 01_RFP 75N95023R00019_031723.pdf is included with the notice to provide this additional information. The response deadline for this procurement is April 3, 2023, and Polina Klimenkova is the designated point of contact.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.